Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 895-904

  Fernandez, M ^a   Porosnicu, M ^a   Markovic, D ^a   Barber, G N ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 4; RECOMBINANT PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER REGRESSION; CANCER SURVIVAL; CANCER THERAPY; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CRICETINAE; DNA, RECOMBINANT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; INTERFERONS; INTERLEUKIN-4; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS; SURVIVAL ANALYSIS; THYMIDINE KINASE; TUMOR CELLS, CULTURED; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0036140461     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.895-904.2002     Document Type: Article

References (29)

1. Stability and commitment in T helper cell development
2. Vesicular stomatitis virus (VSV) therapy of tumors
3. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosls
4. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
5. Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus
6. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
7. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases
8. Gene therapy of experimental brain tumors using neural progenitor cells
9. Virally induced lytic cell death elicits the release of immunogenic grp94/gp96
10. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
11. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
12. Biological behavior of malignant melanoma cells correlated to their survival in vivo
13. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: New strategy for vaccine development
14. In situ use of suicide genes for cancer therapy
15. Cytokine gene therapy of gliomas: Induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity
16. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox
17. Suicide genes: Past, present and future perspectives
18. Recombinant vesicular stomatitis viruses from DNA
19. Interleukin-4 and breast cancer
20. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism
21. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
22. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection
23. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor
24. Recent developments in the virus therapy of cancer
25. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
26. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4
27. Rhabdoviridae: The viruses and their replication
28. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones
29. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice